Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Cash from Financing Activities (2016 - 2026)

Viridian Therapeutics, Inc.\DE has reported Cash from Financing Activities over the past 12 years, most recently at $405.9 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $405.9 million for Q4 2025, up 1042.63% from a year ago — trailing twelve months through Dec 2025 was $426.7 million (down 6.77% YoY), and the annual figure for FY2025 was $426.7 million, down 6.77%.
  • Cash from Financing Activities for Q4 2025 was $405.9 million at Viridian Therapeutics, Inc.\DE, up from $10.9 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for VRDN hit a ceiling of $405.9 million in Q4 2025 and a floor of $108000.0 in Q2 2024.
  • Median Cash from Financing Activities over the past 5 years was $10.0 million (2025), compared with a mean of $77.9 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 99.78% in 2021 and later surged 15202.35% in 2022.
  • Viridian Therapeutics, Inc.\DE's Cash from Financing Activities stood at $170000.0 in 2021, then surged by 15202.35% to $26.0 million in 2022, then skyrocketed by 664.75% to $198.9 million in 2023, then crashed by 82.14% to $35.5 million in 2024, then skyrocketed by 1042.63% to $405.9 million in 2025.
  • The last three reported values for Cash from Financing Activities were $405.9 million (Q4 2025), $10.9 million (Q3 2025), and $764000.0 (Q2 2025) per Business Quant data.